Uniferon® launched in Poland

December 12, 2012

The increasingly competitive pig production industry in Poland has gained access to Uniferon®, the industry-leading injectable iron supplement.

A recent introduction of the industry-leading injectable iron supplement Uniferon® to pig producers in Poland paves the way for even more competitiveness for the Polish pig farmers. The introduction is furthermore another significant step for Pharmacosmos, the Danish pharmaceutical company that has developed and produces Uniferon.

Pharmacosmos is acknowledged as a global leader in iron deficiency treatments for both humans and animals. The company's Uniferon, an all-natural injectable iron supplement for newborn piglets, is used by pig farmers throughout the world.

"Having Uniferon in Poland is a great opportunity to give our piglets the best quality iron available. The decline in pig production and pig population in Poland has made the market even more competitive. Facing this, farmers are looking for the best available management and supplementation of their herds to bring the best possible products to the market. We believe Uniferon to a very promising product as it meets the farmers' needs and expectations," said Tomasz Paluch from Vetoquinol in Poland.

"The introduction in Poland is yet another important step for Pharmacosmos and we believe Vetoquinol to be a very good and professional match for us. Uniferon is approved in Europe, Asia and North America, including FDA approval in the United States, and the Polish pig farmers are now assured an injectable iron that adheres to the highest standards of quality, safety and efficacy. Furthermore, the farmers can join the global best practice community by administering iron to newborn piglets, thus promoting optimal growth and general health as well as avoiding detrimental anaemia," said Jens Fabricius, Vice President, Marketing & Business Operations at Pharmacosmos A/S.

About Vétoquinol

The 10th largest veterinary pharmaceutical company in the world and the 3rd largest dedicated to animal health, Vétoquinol is first and foremost an independent, family-owned business. Historically based in France, Vétoquinol currently develops, produces and distributes a wide range of more than 700 medical and non-medical products in Europe, Americas and Asia-Pacific. With a presence in 23 countries through its subsidiaries, its strong network of 140 distributor partners provides visibility for its products in more than 100 countries.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.